YOLFTbeta
Innovotech Inc

Innovotech Inc

IOT · V · Healthcare / Biotechnology

0.09CAD+0.01 (+12.50%)

Price History

Full chart

Market Stats

Previous Close0.08
Open0.075
Day Range0.07 – 0.09
52-Week Range0.07 – 0.29
Volume212.67K
Market Cap3.54M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta1.24
50-Day Avg0.08
200-Day Avg0.1603

About

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the sector of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Craig Milne B.Sc., M.B.A., Ph.D.
  • Employees0
  • Headquarters2011-94 Street, Edmonton, AB, Canada, T6N 1H1, Canada
  • Websitehttps://innovotech.ca

Leadership

  • Dr. James Timourian Ph.D.Independent Chairman & Secretary
  • Dr. Craig Milne B.Sc., M.B.A., Ph.D.CEO, President & Director
  • Mr. Craig KalvinChief Financial Officer
  • Ms. Jodi McDonald B.Sc.Chief Operating Officer
  • Mr. Roderick Szarka B.ScChief Commercial Officer
  • Dr. Merle OlsonScientific Consultant

Financials

Income Statement

Currency: CAD2003-09-302003-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue00888.82K902.62K707.78K1.01M990.34K826.93K986.23K1.19M1.48M1.13M1.18M2.19M4.53M
Growth (%)---+1.55%-21.59%+42.08%-1.52%-16.50%+19.26%+21.01%+24.17%-24.02%+5.05%+85.56%+106.65%
Cost of Revenue00402.36K334.56K270.72K272.33K290.56K220.61K291.11K326.51K363.15K346.30K700.81K1.08M2.14M
Gross Profit00486.46K568.06K437.06K733.26K699.78K606.32K695.11K866.87K1.12M779.51K481.82K1.11M2.40M
Gross Margin--54.73%62.93%61.75%72.92%70.66%73.32%70.48%72.64%75.49%69.24%40.74%50.59%52.86%
Operating Expense16.69K20.29K1.25M708.65K609.03K647.20K663.76K733.31K715.00K767.56K850.66K919.96K861.49K1.06M2.37M
Operating Income-16.69K-20.29K-766.93K-140.59K-171.97K86.06K36.02K-126.99K-19.89K99.32K267.95K-140.45K-379.67K48.11K23.94K
Operating Margin---86.29%-15.58%-24.30%8.56%3.64%-15.36%-2.02%8.32%18.08%-12.48%-32.10%2.19%0.53%
EBITDA------798.08K-111.62K-29.48K127.25K442.41K-17.33K-78.76K286.36K264.47K
EBITDA Margin------80.59%-13.50%-2.99%10.66%29.86%-1.54%-6.66%13.05%5.83%
Net Income-13.63K-14.53K-827.25K-209.64K-250.60K-215.53K753.38K-127.63K-48.76K106.32K367.13K-136.51K-157.58K224.74K94.38K
Net Income Margin---93.07%-23.23%-35.41%-21.43%76.07%-15.43%-4.94%8.91%24.78%-12.13%-13.32%10.24%2.08%
R&D--206.99K172.43K159.42K148.58K67.50K39.13K23.42K47.96K34.89K110.98K216.54K276.66K523.22K
R&D as % of Total Revenue--23.29%19.10%22.52%14.78%6.82%4.73%2.37%4.02%2.35%9.86%18.31%12.61%11.54%
Interest Expense00000006506.00K3.00K4.38K5.02K5579.96K32.99K
Interest Expense % of Total Revenue--0.00%0.00%0.00%0.00%0.00%0.08%0.61%0.25%0.30%0.45%0.05%0.45%0.73%

Balance Sheet

Currency: CAD2003-09-302003-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets881.62K838.70K423.21K408.86K213.06K325.27K527.26K272.33K274.88K822.44K1.43M1.22M1.22M3.22M4.43M
Total Liabilities40.22K1.75K992.54K1.17M1.22M1.54M345.76K178.86K176.79K177.46K256.04K165.29K217.93K596.80K784.68K
Total Equity841.40K836.94K-569.33K-765.66K-1.00M-1.22M181.51K93.47K98.09K644.98K1.18M1.06M930.60K2.57M3.60M
Cash793.63K751.55K37.12K4.79K32.44K33.17K324.52K28.81K96.67K530.14K422.42K469.07K160.52K725.40K1.62M
Net Debt-------71.19K3.33K------

Cash Flow

Currency: CAD2003-09-302003-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.42K-13.02K-560.96K-87.75K40.90K2.32K-158.69K-280.75K76.30K175.24K25.04K208.39K-228.08K-81.64K-62.35K
Investing Cash Flow-84.16K-74.70K-7.44K4.00K4.00K4.00K-11.57K-9.32K-2.44K-37.69K-60.14K----
Financing Cash Flow604.25K474.76K158.05K55.42K-13.25K-5.59K461.62K-5.65K-6.00K305.92K-72.63K-90.22K-37.59K1.14M878.02K
Capital Expenditure007.44K13.66K13.66K13.66K13.66K9.32K2.44K37.69K60.14K71.52K42.87K202.29K471.52K
Free Cash Flow-------172.36K-290.06K73.86K137.55K-35.10K136.87K-270.96K-283.93K-533.87K
Dividends Paid-----000000-000
FCF to OCF------108.61%103.32%96.80%78.49%-140.14%65.68%118.80%347.77%856.21%
Dividend Paid to FCF------0.00%0.00%0.00%0.00%0.00%-0.00%0.00%0.00%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Nov 16, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022May 23, 2023Aug 15, 2023Nov 3, 2026
EPS Estimate-------------------------------------------------------------------
EPS Actual-0.000.00-0.00-0.00-0.00-0.01-0.02-0.01-0.02-0.01-0.01-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.02-0.02-0.01-0.02-0.010.00-0.01-0.01-0.00-0.00-0.000.01-0.00-0.00-0.00-0.00-0.00-0.000.00-0.000.00-0.000.020.00-0.00-0.00-0.000.00-0.00-0.000.00-0.00-0.000.000.000.000.000.00-0.000.01-0.00-0.000.00-0.00-0.000.00-
Surprise-------------------------------------------------------------------
Timing----------------------------------------------------------------After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap3.54M
Enterprise Value4.14M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.95
Price / Book1.71
EPS-0.01
Book Value0.047
Revenue (TTM)3.72M
Gross Profit (TTM)1.47M
EBITDA-635.47K
Profit Margin-21.10%
Operating Margin-102.56%
Return on Equity-31.31%
Return on Assets-14.81%
Shares Outstanding54.44M
Shares Float30.93M
Beta1.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%